The state-of-the-art UNIQO 160 is EUROIMMUN’s all-in-one system reducing manual working steps, increasing productivity and ensuring maximum diagnostic precision. Full automation of indirect immunofluorescence assays (IFA) from the primary sample to the result proposal makes the instrument an ideal choice for laboratories wanting to take their IFA workflow to the next level. The UNIQO 160 […]
Abnormally elevated blood pressure (hypertension, HT) is a major cause of premature death and a challenge worldwide, with an estimated number of >1 billion adults aged 30–79 years having hypertension, many of them unaware of being affected. Unfortunately, HT can be a symptom of various diseases with very different causes, making diagnostics difficult. The adrenal
Diagnostics using indirect immunofluorescence tests (IFA) cover a wide range of indications and therefore have long been the gold standard in the laboratory. However, despite the many diagnostic applications of this method, evaluating fluorescence patterns can be a real challenge. More than half of the specific patterns that can be found in the evaluation of
Press release, March 3rd 2025 Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus. EUROIMMUN’s Anti-Measles Virus ELISA 2.0 (IgG) is the first of several assays in development expanding EUROIMMUN’s
With passion for rheumatology! Systemic autoimmune rheumatic diseases encompass a wide range of different inflammatory joint, tissue and vascular diseases, such as rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. They are diagnosed on the clinical history, imaging techniques, and serological tests. Antibody detection is a useful diagnostic tool and can provide essential information for
